Latest Product Commercialisation News

Wide Open Agriculture is closing its German plant and pivoting to contract manufacturing in Asia to cut costs and scale lupin ingredient production efficiently under new CEO Craig Swan.

GCM Corporation has inked a binding 24-month joint development agreement with Shenzhen Wanwei Heat Conduction Technology (ALVC) to co-develop a hybrid thermal management product combining vapour chamber and VHD heat sink technologies.

GCM Corporation expands its VHD heat sink portfolio to 44 products and moves into liquid cooling OEM markets for AI servers, securing global distribution via DigiKey.

Eden Innovations has wrapped up the second tranche of its $4 million institutional placement, issuing over 14 million shares at 18 cents each. The capital injection finalises the raise announced in April, with shares issued under ASX rules and ranking equally with existing stock.

OMG Group's net sales hit approximately $6.2 million on a moving annual total basis, marking a 57% increase year-on-year, driven by ecommerce growth and key international distribution deals.

Acrux has amended its licensing agreement with Gedeon Richter to bring its Estradiol spray Lenzetto® to Australia, unlocking up to AUD 5.4 million in milestone payments and addressing a critical shortage in Menopause Hormone Therapy products.

Electro Optic Systems (ASX:EOS) has launched a A$175 million capital raising to complete its MARSS acquisition and accelerate expansion in counter-drone and defence technologies, buoyed by a surge in Middle East orders.

Atomo Diagnostics has closed a modest Share Purchase Plan, raising $44,500 and issuing free attaching options, while reserving a substantial shortfall for future placement.

Sea Forest Limited’s 3Q26 revenue surged 92% to $1.1 million, boosted by expanding SeaFeed™ sales and a pioneering low-carbon wool launch with Theory. New cattle supply deals raise herd commitments to 131,000, underpinning growth amid supportive government policies.

Victory Metals has unlocked a rare metallurgical feat at North Stanmore, achieving a globally top-tier 72% heavy rare earth ratio and unveiling a second revenue stream from zircon-hafnium concentrate using a low-cost gravity separation process.

ClearVue Technologies slashed its quarterly cash burn by 52.7%, trimming $6.9 million in annual costs, as it pushes forward with multiple international solar projects and key product certifications.

EVE Health Group has announced a $1.3 million capital raising through a placement of shares and free attaching options, aimed at advancing its pharmaceutical product rollout and development pipeline. Several components of the offer await shareholder approval at an upcoming general meeting.